VEGFA and age-related macular degeneration: In a study by Starr et al. (2019), which examined 83 eyes from 59 patients with exudative age-related macular degeneration (AMD), the authors demonstrated that telemedicine could effectively facilitate the management of patients receiving intravitreal anti-VEGF therapy.